期刊
SURGERY FOR OBESITY AND RELATED DISEASES
卷 17, 期 12, 页码 1996-2006出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2021.07.019
关键词
TLR4; MyD88; Gastric bypass; Metabolic regulation; Gut microbiome
类别
资金
- VA Merit Review Program [I01 BX004774]
- University of Iowa Department of Internal Medicine and Fraternal Oder of Eagles Diabetes Research Center
- VA CSRD Merit Review Award [1I01CX002212]
- NIAID/NIH [1R01AI137075]
- Carver Trust Medical Research Initiative
- University ofIowa Environmental Health Sciences Research Center, NIEHS/NIH [P30 ES005605]
Toll-like receptor 4 (TLR4) and myeloid differentiation factor 8 (MyD88) play important roles in the metabolic response induced by Roux-en-Y gastric bypass surgery (RYGB), mainly mediated by gut microbiota.
TLR4 knockout mice show attenuated glucose regulatory response to RYGB, while MyD88 knockout mice do not respond to the metabolic effects induced by RYGB.
Fecal microbiota transplant from RYGB-operated mice fails to induce a metabolic phenotype similar to that of the donors in TLR4 and MyD88 KO mice, but is successful in wild-type recipients.
Background: Toll-like receptor 4 (TLR4) has been suggested as one of the forefront cross-communicators between the intestinal bacteria and the host to regulate inflammatory signals and energy homeostasis. High-fat diet-induced inflammation is mediated by changes in gut microbiota and requires a functional TLR-4, the deficiency of which renders mice resistant to diet-induced obesity and its associated metabolic dysfunction. Furthermore, gut microbiota was suggested to play a key role in the beneficial effects of Roux-en-Y gastric bypass (RYGB), a commonly performed bariatric procedure. Objectives: To explore whether TLR4, myeloid differentiation factor 8 (MyD88; 1 of its key downstream signaling regulators) and gut microbiota play an integrative role in RYGB-induced metabolic outcomes. Setting: Animal- based study. Method: We performed RYGB in TLR4 and MyD88 knock-out (KO) mice and used fecal microbiota transplant (FMT) from RYGB-operated animals to these genetic mouse models to address our questions. Results: We demonstrate that RYGB reduces TLR4 expression explicitly in the small and large intestine of C57B1c/6J mice. We also show that TLR4 KO mice have an attenuated glucoregulatory response to RYGB. In addition, we reveal that MyD88 KO mice fail to respond to all RYGB-induced metabolic effects. Finally, fecal microbiota transplant from RYGB-operated mice into TLR4 KO and MyD88 KO naive recipients fails to induce a metabolic phenotype similar to that of the donors, as it does in wild-type recipients. Conclusion: TLR4 and MyD88 are required for RYGB-induced metabolic response that is likely mediated by gut microbiome. Published by Elsevier Inc. on behalf of American Society for Bariatric Surgery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据